CHUV
Les activités du CHUV
MENU
Service de gastro-entérologie
et d’hépatologie
Accueil > Recherche > Publications > 2011

2011


Articles originaux

  • 1. Akazawa D, Morikawa K, Omi N, Takahashi H, Nakamura N, Mochizuki H, Date T, Ishii K, Suzuki T, Wakita T. Production and characterization of HCV particles from serum-free culture. Vaccine 2011;29:4821-4828.

  • 2. Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, Brientini MP, Richou C, Minello A, Antonino AT, Gillet M, Ito A, Mantion GA, Vuitton DA. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Liver Transpl 2011;17:855-865.

  • 3. Cai T, Dufour J-F, Müllhaupt B, Gerlach T, Heim M, Moradpour D, Cerny A, Malinverni R, Kaddai V, Bochud M, Negro F, Bochud P-Y on behalf of the Swiss Hepatitis C Cohort Study Group. Viral genotype-specific role of PNPLA3, PPARG, MTTP and IL28B in hepatitis C virus-associated steatosis. J Hepatol 2011;55:529-535.

  • 4. Camara RJ, Schoepfer AM, Pittet V, Begré S, von Känel R, and the Swiss IBD cohort study group. Mood and non-mood components of perceived stress and exacerbation of Crohn’s disease. Inflamm Bowel Dis 2011;17:2358-2365.

  • 5. Farnik H, Lange CM, Hofmann WP, Berger A, Allwinn R, Welker MW, Trojan J, Sarrazin C, Herrmann E, Zeuzem S, Kronenberger B. Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B. J Clin Virol 2011;52:204-209.

  • 6. Favre L, Borle F, Velin D, Bachmann D, Bouzourene H, Wagnières G, van den Bergh H, Ballabeni P, Gabrecht T, Michetti P, Schreiber S, Ortner MA. Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis. Endoscopy 2011;43:604-616.

  • 7. Hruz P, Straumann A, Bussmann C, Heer P, Simon HU, Zwahlen M, Beglinger C, Schoepfer AM; Swiss EoE Study Group. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland [Letter]. J Allergy Clin Immunol 2011;128:1349-1350.

  • 8. Kaufmann A, Kenfak-Foguena A, André C, Canellini G, Bürgisser P, Moradpour D, Darling KEA, Cavassini M. Hepatitis E virus seroprevalence among blood donors in Southwest Switzerland. PLoS One 2011;6:e21150

  • 9. Kenfak Foguena A, Schöni-Affolter F, Bürgisser P, Wittek A, Darling KEA, Kovari H, Kaiser L, Evison J-M, Elzi L, Gurtner-De La Fuente V, Jost J, Moradpour D, Abravanel F, Izopet J, Cavassini M, and the Swiss HIV Cohort Study. Hepatitis E virus seroprevalence and chronic infection in HIV-infected patients with unexplained ALT elevation in the Swiss HIV Cohort Study. Emerg Infect Dis 2011;17:1074-1078.

  • 10. Lange CM, Moradpour D, Doehring A, Lehr HA, Müllhaupt B, Bibert S, Bochud PY, Antonino AT, Pascual M, Farnik H, Shi Y, Bechstein WO, Moench C, Hansmann ML, Sarrazin C, Lötsch J, Zeuzem S, Hofmann WP. Impact of donor and recipient IL28Brs12979860 genotypes on hepatitis C virus liver graft reinfection. J Hepatol 2011;55:322-327.

  • 11. Lange CM, Susser S, Herrmann E, Karey U, Kieffer TL, Kwong AD, Schinkel J, Reesink HW, Zeuzem S, Sarrazin C. HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2a. Scand J Gastroenterol 2011,46:1362-8

  • 12. Leblanc S, Allez M, Seksik P, Flourié B, Peeters H, Dupas JL, Bouguen G, Peyrin-Biroulet L, Duclos b, Bourreille A, Dewit O, Bouhnik Y, Michetti P, Chaussade S, Saussure P, Mary JY, Colombel JF, Lémann M. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol 2011;106:771-777

  • 13. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, Wershil DK, Rothenberg ME, Aceves SS. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011:41:630-639.

  • 14. Niederhauser J, Lobrinus JA, Ochsner F, Wider C, Fellmann F, Yerly P, Antonino AT, Saraiva MJ, Moradpour D, Kuntzer T. Successful heart and liver transplantation in a Swiss patient with Glu89Lys transthyretin amyloidosis [Letter]. Transplantation 2011;91:e40-e42.

  • 15. Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Flechter JG, Chowers Y, D’Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV, Louis E, Michetti P, Munkholm P, Oresland T, Panés J, Peyrin-Biroulet L, Reinisch W, Sands BE, Schoelmerich J, Schreiber S, Tilg H, Travis S, van Assche G, Vecchi M, Mary JY, Colombel JF, Lémann M. Development of the Crohn’s disease digestive damage score, the Lémann score. Inflamm Bowel Dis 2011:17:1415-1422.

  • 16. Paul D, Romero-Brey I, Gouttenoire J, Stoitsova S, Krijnse-Locker J, Moradpour D, Bartenschlager R. NS4B self-interaction through conserved C-terminal elements is required for the establishment of functional hepatitis C virus replication complexes. J Virol 2011;85:6963-6976.

  • 17. Perreau M, Welles HC, Harari A, Hall O, Martin R, Maillard M, Dorta G, Bart PA, Kremer EJ, Tartaglia J, Wagner R, Esteban M, Levy Y, Pantaleo G.DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell responses in Intestinal Mucosa. J Virol 2011;85:9854-9862.

  • 18. Popescu C-I, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, Duverlie G, Penin F, Héliot L, Rouillé Y, Dubuission J. NS2 protein of hepatitis C virus interacts with structural and nonstructural proteins towards virus assembly. PLoS Pathog 2011;7:e1001278.

  • 19. Straumann A, Safroneeva E, Schoepfer AM. Placebo and other interventions in asthma [Letter]. N Engl J Med 2011;365:1446-1447.

  • 20. Straumann A, Conus S, Bussmann C, Degen L, Frei C, Beglinger C, Schoepfer AM, Simon HU. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011;9:400-409.

  • 21. Vavricka SR, Schoepfer AM, Bansky G, Binek J, Felley C, Geyer M, Manz M, Rogler G, de Saussure P, Sauter B, Scharl M, Seibold F, Straumann A, Michetti P, Swiss IBDnet. Efficacy and safety of certolizumab pegol in an unselected Crohn’s disease population: 26 week data of the FACTS II survey. Inflamm Bowel Dis 2011:17:1530-1539.

  • 22. Velin D, Narayan S, Bernasconi E, Busso N, Ramelli G, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Michetti P, So A. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice. Gastroenterology 2011;141:1273-1282.


Articles de revue


  • 1. Badel S, Dorta G, Carron PN. Upper gastrointestinal bleeding: usefulness of prognostic scores. Rev Med Suisse 2011;7:1574-1578.

  • 2. Dehlavi A, Nichita C, Kessler Brondolo V, Bertolini D, Dorta G. Prévention du cancer colo-rectal. Rev Med Suisse 2011;7:1704-1709.

  • 3. Fournier J, Pouget R, Perrier P, Nichita C. Panniculite pancréatique sur fistule pancréatico-portale. Schweiz Med Forum 2011;11:503-505.

  • 4. Froehlich F. Is cold biopsy forceps resection of diminutive polyps really so inadequate? Endoscopy 2011;43:1015.

  • 5. Godat S, Moradpour D, Schoepfer A. Oesophagite à éosinophiles : mise à jour 2011. Rev Med Suisse 2011;7:1678-1682.

  • 6. Hiroz P, Antonino A, Doerig C, Pache I, Moradpour D. La maladie de Wilson : un caméléon clinique auquel il faut penser. Rev Med Suisse 2011;7:1690-1695.

  • 7. Lange CM, Zeuzem S. IL28B polymorphisms in the treatment of chronic hepatitis C. J Hepatol 2011;55:692-701.

  • 8. Lange CM, Zeuzem S. Diacylglycerol acyltransferase-1 : a critical host factor for hepatitis C virus assembly and potential new drug target. Gastroenterology 2011;140:1345-1347.

  • 9. Manuel O, Baid-Agrawal S, Moradpour D, Pascual M. Immunosuppression in HCV-infected patients after renal transplantation. Contrib Nephrol 2011;176:97-107.

  • 10. Manz M, Michetti P, Seibold F, Rogler G, Beglinger C. Treatment algorithm for moderate to severe ulcerative colitis. Swiss Med Weekly 2011:141:w13235.

  • 11. Mentha G, Majno P, Morard I, Toso C, Moldovan B, Antonino A, Berney T, Morel P, Rubbia-Brandt L, Terraz S, Moradpour D, Hadengue A, Giostra E. La transplantation hépatique. Rev Med Suisse 2011;7:192-193.

  • 12. Moradpour D. Neues aus der Hepatologie [Editorial]. Ther Umsch 2011;68:173-174.

  • 13. Moradpour D and Blum HE. Virushepatitis. Ther Umsch 2011;68:175-181.

  • 14. Moradpour D and Hadengue A. L'ère qui s'ouvre dans la prise en charges des patients atteints d'hépatite C [Editorial]. Rev Med Suisse 2011;7:1667-1668.

  • 15. Morikawa K, Lange CM, Gouttenoire J, Brass V, Penin F, Moradpour D. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat 2011;18:305-315.

  • 16. Pache I. Prise en charge de la cirrhose par le praticien. Rev Med Suisse 2011;26;7:235-236.

  • 17. Rogler G, Beglinger C, Mottet C, Seibold F, Gross V. [Topical therapy of ulcerative colitis]. Praxis 2011;100:1413-1424.

  • 18. Schoepfer A, Pache I, Nichita C, Dorta G, Moradpour D. Actualités en gastro-entérologie et hépatologie. Rev Med Suisse 2011;7:25-29.

  • 19. Schoepfer AM, Simon D, Straumann A. Eosinophilic esophagitis - latest intelligence. Clin Exp Allergy 2011;41:630-639.